Generated by AI
Global X Genomics & Biotechnology ETF is an exchange-traded fund that provides focused exposure to companies involved in genomic science and biotechnology. The fund tracks the Solactive Genomics Index and invests primarily in businesses engaged in gene editing, genomic sequencing, genetic medicine and therapy, computational genomics, and related life sciences applications. Its portfolio is concentrated in healthcare and biotechnology firms, including developers of diagnostics, research tools, and advanced therapeutics that support innovation across precision medicine and biological research. By targeting this specialized segment of the market, Global X Genomics & Biotechnology ETF offers investors a single fund that reflects the growth and commercialization of genomics-driven technologies and services across global healthcare and biotech industries.
Summary of Jun 30's posts. Generated by AI.
Summary of Jul 18's posts. Generated by AI.
No summary yet.
Summary of Jun 30's posts. Generated by AI.
Investors talking about GNOM also mention these. Each card shows that asset’s own numbers for the past 24 hours.